BLACKLEDGER Market Trends: DNN, CRSP, SOFI
BLACKLEDGER's latest market trend watch update tracks DNN, CRSP, SOFI, AVAX, INJ, SOL from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Market Trend Data
The dedicated feed category for this update is Market Trends. The latest public scan timestamp is 2026-07-25T08:00:41.396030+00:00.
- DNN (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- CRSP (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- SOFI (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- AVAX (crypto): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- INJ (crypto): Bull public bias, Extended, public score 9.0/10, status: Paper trading research.
- SOL (crypto): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- ABOS (stock): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- PLTR (stock): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
DNN Public Research Bio
Name: Denison Mines Corp.. Market class: stock. Public bias: Bear. Public tier: Extended.
Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. It holds 95% interest in its flagship project Wheeler River uranium project located in the Athabasca Basin region in northern Saskatchewan. The company was formerly known as International Uranium Corporation and changed its name to Denison Mines Corp. in December 2006. The company was founded in 1954 and is headquartered in Toronto, Canada.
- Latest public price/reference: $2.91
- Public market capitalization: $2.63B
- Recent public volume/reference: 22.80M
- One-month public movement: -3.0%
- Sector/category: Energy
Why DNN Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Denison Mines (TSX:DML) Could Be A Bargain Following Its Split Fair Value Debate — Simply Wall St.
- Foremost Clean Energy targets Athabasca growth after Hatchet Lake Uranium success — Proactive
- Can Cameco's Contract Portfolio Power Its Next Growth Phase? — Zacks
- Nuclear Energy Stocks Gain From Growing Need for Reliable Clean Power — Zacks
CRSP Public Research Bio
Name: CRISPR Therapeutics AG. Market class: stock. Public bias: Bear. Public tier: Extended.
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting allogeneic chimeric antigen receptor T cell for autoimmune indications and oncology. The company's lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemog
- Latest public price/reference: $46.54
- Public market capitalization: $4.58B
- Recent public volume/reference: 1.32M
- One-month public movement: -7.35%
- Sector/category: Healthcare
Why CRSP Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know — Zacks
- Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating — Motley Fool
- 3 Promising Genomics Stocks to Add to Your Portfolio in 2026 — Zacks
- Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued? — Simply Wall St.
SOFI Public Research Bio
Name: SoFi Technologies, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
SoFi Technologies, Inc. provides various financial services in the United States, Latin America, Canada, and Hong Kong. The company operates through three segments: Lending, Technology Platform, and Financial Services. It offers lending and financial services and products that allows its members to borrow, save, spend, invest, and protect money; and personal loans, student loans, home loans, and related services. The company also operates Galileo, a technology platform that offers services to financial and non-financial institution; and Technisys, a cloud-native digital and core banking platform that provides software licenses and associated services, including implementation and maintenance. In addition, it provides SoFi Money offers checking and savings accounts, and cash management products; SoFi Invest, a mobile-first investment platform that offers access to trading and advisory solutions, such as investing and robo-advisory; and S
- Latest public price/reference: $16.46
- Public market capitalization: $21.11B
- Recent public volume/reference: 92.50M
- One-month public movement: -1.26%
- Sector/category: Financial Services
Why SOFI Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Is SoFi Technologies Stock a Bargain After Its Big Drop, or a Falling Knife? — Motley Fool
- Unveiling SoFi Technologies (SOFI) Q2 Outlook: Wall Street Estimates for Key Metrics — Zacks
- Coinbase vs. SoFi: Two High-Growth Stocks, One Better Investment — 24/7 Wall St.
- Primis Financial (FRST) Lags Q2 Earnings Estimates — Zacks
AVAX Public Research Bio
Name: Avalanche USD. Market class: crypto. Public bias: Bear. Public tier: Extended.
Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 463,441,061.1772119 with 431,771,961.1772119 in circulation. The last known price of Avalanche is 6.19744931 USD and is down -4.08 over the last 24 hours. It is currently trading on 1100 active market(s) with $268,552,202.67 traded over the last 24 hours. More information can be found at https://avax.network/.
- Latest public price/reference: $6.24
- Public market capitalization: $2.70B
- Recent public volume/reference: 236.45M
- One-month public movement: -5.17%
- Sector/category: not available
Why AVAX Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Aptos climbs to the top 4 blockchains in transaction count — TheStreet
- How tokenized stocks could become a $3 trillion market — Yahoo Finance Video
- BlackRock's BUIDL Nears $1 Billion Milestone on Avalanche as Real-World Asset Boom Accelerates — CCN
- 5 Altcoins Stand to Gain From Tokenized Stocks, Grayscale Says — BeInCrypto
INJ Public Research Bio
Name: Injective USD. Market class: crypto. Public bias: Bull. Public tier: Extended.
Injective (INJ) is a cryptocurrency and operates on the Ethereum platform. Injective has a current supply of 100,000,000 with 99,970,954.5 in circulation. The last known price of Injective is 4.858592 USD and is up 5.78 over the last 24 hours. It is currently trading on 583 active market(s) with $92,216,272.60 traded over the last 24 hours. More information can be found at https://injective.com.
- Latest public price/reference: $5.194
- Public market capitalization: $520.86M
- Recent public volume/reference: 88.09M
- One-month public movement: 7.01%
- Sector/category: not available
Why INJ Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Top 3 Altcoins to Watch For Fourth Week of July 2026 — BeInCrypto
- Injective’s Form TA-1 Explained: The Transfer Agent Filing Reshaping INJ’s Future — 99bitcoins
- DAT Accumulates 7% of Injective (INJ) Supply – Is It Enough to Spark a Rally? — BeInCrypto
- Valereum joins up with Injective and DigiShares to deliver compliant RWA tokenisation — Proactive
SOL Public Research Bio
Name: Solana USD. Market class: crypto. Public bias: Bear. Public tier: Extended.
Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 630,867,471.17279017 with 582,864,816.14035106 in circulation. The last known price of Solana is 74.41939808 USD and is down -3.07 over the last 24 hours. It is currently trading on 1147 active market(s) with $1,576,911,918.67 traded over the last 24 hours. More information can be found at https://solana.com.
- Latest public price/reference: $73.71
- Public market capitalization: $43.02B
- Recent public volume/reference: 1.55B
- One-month public movement: 2.61%
- Sector/category: not available
Why SOL Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Morgan Stanley bitcoin trust tops $400 million in inflows — Yahoo Finance Video
- Top Cryptocurrencies Fall; Bitcoin Holds Above $64,000 — MT Newswires
- Aptos climbs to the top 4 blockchains in transaction count — TheStreet
- Why Are CRCL, COIN Stocks Rising Pre-Market Despite Bitcoin’s Dip, Price Target Cuts? — Stocktwits
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Market Trends section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.